Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent Vaccine.

van Westen E, Knol MJ, Wijmenga-Monsuur AJ, Tcherniaeva I, Schouls LM, Sanders EAM, van Els CACM, Berbers GAM, Rots NY.

Vaccines (Basel). 2018 Dec 11;6(4). pii: E82. doi: 10.3390/vaccines6040082.

2.

Outbreak of NDM-1-Producing Klebsiella pneumoniae in a Dutch Hospital, with Interspecies Transfer of the Resistance Plasmid and Unexpected Occurrence in Unrelated Health Care Centers.

Bosch T, Lutgens SPM, Hermans MHA, Wever PC, Schneeberger PM, Renders NHM, Leenders ACAP, Kluytmans JAJW, Schoffelen A, Notermans D, Witteveen S, Bathoorn E, Schouls LM.

J Clin Microbiol. 2017 Aug;55(8):2380-2390. doi: 10.1128/JCM.00535-17. Epub 2017 May 17.

3.

Changing characteristics of livestock-associated meticillin-resistant Staphylococcus aureus isolated from humans - emergence of a subclade transmitted without livestock exposure, the Netherlands, 2003 to 2014.

Bosch T, van Luit M, Pluister GN, Frentz D, Haenen A, Landman F, Witteveen S, van Marm-Wattimena N, van der Heide HG, Schouls LM.

Euro Surveill. 2016 May 26;21(21). doi: 10.2807/1560-7917.ES.2016.21.21.30236.

4.

Next-Generation Sequencing Confirms Presumed Nosocomial Transmission of Livestock-Associated Methicillin-Resistant Staphylococcus aureus in the Netherlands.

Bosch T, Witteveen S, Haenen A, Landman F, Schouls LM.

Appl Environ Microbiol. 2016 Jun 30;82(14):4081-4089. doi: 10.1128/AEM.00773-16. Print 2016 Jul 15.

5.

Monitoring the spread of meticillin-resistant Staphylococcus aureus in The Netherlands from a reference laboratory perspective.

Donker T, Bosch T, Ypma RJ, Haenen AP, van Ballegooijen WM, Heck ME, Schouls LM, Wallinga J, Grundmann H.

J Hosp Infect. 2016 Aug;93(4):366-74. doi: 10.1016/j.jhin.2016.02.022. Epub 2016 Mar 15.

6.

The population structure of Staphylococcus aureus in China and Europe assessed by multiple-locus variable number tandem repeat analysis; clues to geographical origins of emergence and dissemination.

Yan X, Schouls LM, Pluister GN, Tao X, Yu X, Yin J, Song Y, Hu S, Luo F, Hu W, He L, Meng F, Donker T, Tsompanidou E, van Dijl JM, Zhang J, Grundmann H.

Clin Microbiol Infect. 2016 Jan;22(1):60.e1-60.e8. doi: 10.1016/j.cmi.2015.08.022. Epub 2015 Sep 3.

7.

Whole-Genome Mapping as a Novel High-Resolution Typing Tool for Legionella pneumophila.

Bosch T, Euser SM, Landman F, Bruin JP, IJzerman EP, den Boer JW, Schouls LM.

J Clin Microbiol. 2015 Oct;53(10):3234-8. doi: 10.1128/JCM.01369-15. Epub 2015 Jul 22.

8.

Multiple-locus variable number tandem repeat analysis is superior to spa typing and sufficient to characterize MRSA for surveillance purposes.

Bosch T, Pluister GN, van Luit M, Landman F, van Santen-Verheuvel M, Schot C, Witteveen S, van der Zwaluw K, Heck ME, Schouls LM.

Future Microbiol. 2015;10(7):1155-62. doi: 10.2217/fmb.15.35.

PMID:
26173807
9.

Detection and serotyping of pneumococci in community acquired pneumonia patients without culture using blood and urine samples.

Elberse K, van Mens S, Cremers AJ, Meijvis SC, Vlaminckx B, de Jonge MI, Meis JF, Blauwendraat C, van de Pol I, Schouls LM.

BMC Infect Dis. 2015 Feb 13;15:56. doi: 10.1186/s12879-015-0788-0.

10.

Livestock-associated MRSA: innocent or serious health threat?

Bosch T, Schouls LM.

Future Microbiol. 2015;10(4):445-7. doi: 10.2217/fmb.15.1. No abstract available.

11.

Next-generation sequencing of carbapenem-resistant Gram-negative microorganisms: a key tool for surveillance and infection control.

Bootsma HJ, Schouls LM.

Future Microbiol. 2015;10(3):299-302. doi: 10.2217/fmb.14.134. No abstract available.

12.

The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in gram-negative rods.

van der Zwaluw K, de Haan A, Pluister GN, Bootsma HJ, de Neeling AJ, Schouls LM.

PLoS One. 2015 Mar 23;10(3):e0123690. doi: 10.1371/journal.pone.0123690. eCollection 2015.

13.

Studying Bordetella pertussis populations by use of SNPeX, a simple high-throughput single nucleotide polymorphism typing method.

Zeddeman A, Witteveen S, Bart MJ, van Gent M, van der Heide HG, Heuvelman KJ, Schouls LM, Mooi FR.

J Clin Microbiol. 2015 Mar;53(3):838-46. doi: 10.1128/JCM.02995-14. Epub 2015 Jan 7.

14.

The dynamic changes of dominant clones of Staphylococcus aureus causing bloodstream infections in the European region: results of a second structured survey.

Grundmann H, Schouls LM, Aanensen DM, Pluister GN, Tami A, Chlebowicz M, Glasner C, Sabat AJ, Weist K, Heuer O, Friedrich AW; ESCMID Study Group on Molecular Epidemiological Markers; European Staphylococcal Reference Laboratory Working Group.

Euro Surveill. 2014 Dec 11;19(49). pii: 20987.

15.

Transmission and persistence of livestock-associated methicillin-resistant Staphylococcus aureus among veterinarians and their household members.

Bosch T, Verkade E, van Luit M, Landman F, Kluytmans J, Schouls LM.

Appl Environ Microbiol. 2015 Jan;81(1):124-9. doi: 10.1128/AEM.02803-14. Epub 2014 Oct 17.

16.

Bacteraemic and non-bacteraemic/urinary antigen-positive pneumococcal community-acquired pneumonia compared.

van Mens SP, van Deursen AMM, de Greeff SC, de Melker HE, Schouls LM, van der Ende A, Bonten MJM, Sanders EAM, Vlaminckx BJM.

Eur J Clin Microbiol Infect Dis. 2015 Jan;34(1):115-122. doi: 10.1007/s10096-014-2209-5. Epub 2014 Aug 1.

PMID:
25079513
17.

Dynamics of methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus carriage in pig farmers: a prospective cohort study.

van Cleef BA, van Benthem BH, Verkade EJ, van Rijen M, Kluytmans-van den Bergh MF, Schouls LM, Duim B, Wagenaar JA, Graveland H, Bos ME, Heederik D, Kluytmans JA.

Clin Microbiol Infect. 2014 Oct;20(10):O764-71. doi: 10.1111/1469-0691.12582. Epub 2014 May 15.

18.

Increased incidence of serotype-1 invasive pneumococcal disease in young female adults in The Netherlands.

Van Mens SP, Van Deursen AM, Meijvis SC, Vlaminckx BJ, Sanders EA, De Melker HE, Schouls LM, Van Der Ende A, De Greeff SC, Rijkers GT.

Epidemiol Infect. 2014 Sep;142(9):1996-9. doi: 10.1017/S0950268813002860. Epub 2013 Nov 11.

PMID:
24229845
19.

Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial.

Spijkerman J, Veenhoven RH, Wijmenga-Monsuur AJ, Elberse KE, van Gageldonk PG, Knol MJ, de Melker HE, Sanders EA, Schouls LM, Berbers GA.

JAMA. 2013 Sep 4;310(9):930-7. doi: 10.1001/jama.2013.228052.

PMID:
24002279
20.

Use of multilocus variable-number tandem repeat analysis (MLVA) in eight European countries, 2012.

Lindstedt BA, Torpdahl M, Vergnaud G, Le Hello S, Weill FX, Tietze E, Malorny B, Prendergast DM, Ní Ghallchoir E, Lista RF, Schouls LM, Söderlund R, Börjesson S, Åkerström S.

Euro Surveill. 2013 Jan 24;18(4):20385.

21.

Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands.

van Deursen AM, van Mens SP, Sanders EA, Vlaminckx BJ, de Melker HE, Schouls LM, de Greeff SC, van der Ende A; Invasive Pneumococcal Disease Sentinel Surveillance Laboratory Group.

Emerg Infect Dis. 2012 Nov;18(11):1729-37. doi: 10.3201/eid1811.120329.

22.

High genetic diversity of Staphylococcus aureus strains colonizing patients with epidermolysis bullosa.

van der Kooi-Pol MM, Veenstra-Kyuchukova YK, Duipmans JC, Pluister GN, Schouls LM, de Neeling AJ, Grundmann H, Jonkman MF, van Dijl JM.

Exp Dermatol. 2012 Jun;21(6):463-6. doi: 10.1111/j.1600-0625.2012.01502.x.

PMID:
22621190
23.

Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine.

Elberse KE, van der Heide HG, Witteveen S, van de Pol I, Schot CS, van der Ende A, Berbers GA, Schouls LM.

Vaccine. 2012 Dec 14;30(52):7644-51. doi: 10.1016/j.vaccine.2012.04.021. Epub 2012 Apr 19.

PMID:
22521844
24.

Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus.

Smits GP, van Gageldonk PG, Schouls LM, van der Klis FR, Berbers GA.

Clin Vaccine Immunol. 2012 Mar;19(3):396-400. doi: 10.1128/CVI.05537-11. Epub 2012 Jan 11.

25.
26.

Population structure of invasive Streptococcus pneumoniae in The Netherlands in the pre-vaccination era assessed by MLVA and capsular sequence typing.

Elberse KE, van de Pol I, Witteveen S, van der Heide HG, Schot CS, van Dijk A, van der Ende A, Schouls LM.

PLoS One. 2011;6(5):e20390. doi: 10.1371/journal.pone.0020390. Epub 2011 May 26.

27.

Multiple-locus variable number tandem repeat analysis for Streptococcus pneumoniae: comparison with PFGE and MLST.

Elberse KE, Nunes S, Sá-Leão R, van der Heide HG, Schouls LM.

PLoS One. 2011;6(5):e19668. doi: 10.1371/journal.pone.0019668. Epub 2011 May 26.

28.

Seroprevalence of IgG antibodies against 13 vaccine Streptococcus pneumoniae serotypes in the Netherlands.

Elberse KE, de Greeff SC, Wattimena N, Chew W, Schot CS, van de Pol JE, van der Heide JG, van der Ende A, van der Klis FR, Berbers GA, Schouls LM.

Vaccine. 2011 Jan 29;29(5):1029-35. doi: 10.1016/j.vaccine.2010.11.054. Epub 2010 Dec 1.

PMID:
21129397
29.

Multiple-locus variable-number tandem repeat analysis of Neisseria gonorrhoeae.

Heymans R, Schouls LM, van der Heide HG, van der Loeff MF, Bruisten SM.

J Clin Microbiol. 2011 Jan;49(1):354-63. doi: 10.1128/JCM.01059-10. Epub 2010 Nov 17.

30.

Incidence of low-grade infection in aseptic loosening of total hip arthroplasty.

Moojen DJ, van Hellemondt G, Vogely HC, Burger BJ, Walenkamp GH, Tulp NJ, Schreurs BW, de Meulemeester FR, Schot CS, van de Pol I, Fujishiro T, Schouls LM, Bauer TW, Dhert WJ.

Acta Orthop. 2010 Dec;81(6):667-73. doi: 10.3109/17453674.2010.525201. Epub 2010 Oct 4.

31.

Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands.

Rodenburg GD, de Greeff SC, Jansen AG, de Melker HE, Schouls LM, Hak E, Spanjaard L, Sanders EA, van der Ende A.

Emerg Infect Dis. 2010 May;16(5):816-23. doi: 10.3201/eid1605.091223.

32.

Vaccine preventability of meningococcal clone, Greater Aachen Region, Germany.

Elias J, Schouls LM, van de Pol I, Keijzers WC, Martin DR, Glennie A, Oster P, Frosch M, Vogel U, van der Ende A.

Emerg Infect Dis. 2010 Mar;16(3):465-72. doi: 10.3201/eid1603.091102.

33.

PFGE diversity within the methicillin-resistant Staphylococcus aureus clonal lineage ST398.

Bosch T, de Neeling AJ, Schouls LM, van der Zwaluw KW, Kluytmans JA, Grundmann H, Huijsdens XW.

BMC Microbiol. 2010 Feb 9;10:40. doi: 10.1186/1471-2180-10-40.

35.

Invasive pneumococcal disease in the Netherlands: Syndromes, outcome and potential vaccine benefits.

Jansen AG, Rodenburg GD, de Greeff SC, Hak E, Veenhoven RH, Spanjaard L, Schouls LM, Sanders EA, van der Ende A.

Vaccine. 2009 Apr 14;27(17):2394-401. doi: 10.1016/j.vaccine.2009.01.127. Epub 2009 Feb 6.

PMID:
19428856
36.

Multiple-locus variable number tandem repeat analysis of Staphylococcus aureus: comparison with pulsed-field gel electrophoresis and spa-typing.

Schouls LM, Spalburg EC, van Luit M, Huijsdens XW, Pluister GN, van Santen-Verheuvel MG, van der Heide HG, Grundmann H, Heck ME, de Neeling AJ.

PLoS One. 2009;4(4):e5082. doi: 10.1371/journal.pone.0005082. Epub 2009 Apr 3.

37.

Validation of PCR-reverse line blot, a method for rapid detection and identification of nine dermatophyte species in nail, skin and hair samples.

Bergmans AM, Schouls LM, van der Ent M, Klaassen A, Böhm N, Wintermans RG.

Clin Microbiol Infect. 2008 Aug;14(8):778-88. doi: 10.1111/j.1469-0691.2008.02036.x.

38.

Pre-admission clinical course of meningococcal disease and opportunities for the earlier start of appropriate intervention: a prospective epidemiological study on 752 patients in the Netherlands, 2003-2005.

de Greeff SC, de Melker HE, Schouls LM, Spanjaard L, van Deuren M.

Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):985-92. doi: 10.1007/s10096-008-0535-1. Epub 2008 May 21.

PMID:
18493804
39.

Molecular identification of bloodmeal source in Ixodes ricinus ticks using 12S rDNA as a genetic marker.

Humair PF, Douet V, Morán Cadenas F, Schouls LM, Van De Pol I, Gern L.

J Med Entomol. 2007 Sep;44(5):869-80.

PMID:
17915521
40.

[Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk].

de Greeff SC, Sanders EA, de Melker HE, van der Ende A, Vermeer PE, Schouls LM.

Ned Tijdschr Geneeskd. 2007 Jun 30;151(26):1454-7. Review. Dutch.

PMID:
17633974
41.

Identification of orthopaedic infections using broad-range polymerase chain reaction and reverse line blot hybridization.

Moojen DJ, Spijkers SN, Schot CS, Nijhof MW, Vogely HC, Fleer A, Verbout AJ, Castelein RM, Dhert WJ, Schouls LM.

J Bone Joint Surg Am. 2007 Jun;89(6):1298-305.

PMID:
17545434
42.

Dynamics in prophage content of invasive and noninvasive M1 and M28 Streptococcus pyogenes isolates in The Netherlands from 1959 to 1996.

Vlaminckx BJ, Schuren FH, Montijn RC, Caspers MP, Beitsma MM, Wannet WJ, Schouls LM, Verhoef J, Jansen WT.

Infect Immun. 2007 Jul;75(7):3673-9. Epub 2007 Apr 23.

43.

Determination of the relationship between group A streptococcal genome content, M type, and toxic shock syndrome by a mixed genome microarray.

Vlaminckx BJ, Schuren FH, Montijn RC, Caspers MP, Fluit AC, Wannet WJ, Schouls LM, Verhoef J, Jansen WT.

Infect Immun. 2007 May;75(5):2603-11. Epub 2007 Feb 26.

44.

Longitudinal analysis of tick densities and Borrelia, Anaplasma, and Ehrlichia infections of Ixodes ricinus ticks in different habitat areas in The Netherlands.

Wielinga PR, Gaasenbeek C, Fonville M, de Boer A, de Vries A, Dimmers W, Akkerhuis Op Jagers G, Schouls LM, Borgsteede F, van der Giessen JW.

Appl Environ Microbiol. 2006 Dec;72(12):7594-601. Epub 2006 Oct 6.

45.

Genes for the majority of group a streptococcal virulence factors and extracellular surface proteins do not confer an increased propensity to cause invasive disease.

McMillan DJ, Beiko RG, Geffers R, Buer J, Schouls LM, Vlaminckx BJ, Wannet WJ, Sriprakash KS, Chhatwal GS.

Clin Infect Dis. 2006 Oct 1;43(7):884-91. Epub 2006 Aug 23.

PMID:
16941370
46.

Introduction of pneumococcal conjugate vaccine into the Dutch national immunisation programme.

van Oosten M, de Greeff SC, Spanjaard L, Schouls LM.

Euro Surveill. 2006 Jun 8;11(6):E060608.2. No abstract available.

PMID:
16819118
47.

"Mycobacterium tilburgii" infections.

Wagner D, Vos M, Buiting AG, Serr A, Bergmans AM, Kern W, Schouls LM.

Emerg Infect Dis. 2006 Mar;12(3):532-4. No abstract available.

48.

The epidemiology of Haemophilus influenzae type b meningitis in Burkina Faso.

Yaro S, Lourd M, Naccro B, Njanpop-Lafourcade BM, Hien A, Ouedraogo MS, Traore Y, Schouls LM, Parent du Châtelet I, Gessner BD; Clinical Group; Laboratory Group.

Pediatr Infect Dis J. 2006 May;25(5):415-9.

PMID:
16645505
49.
50.

Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands.

de Greeff SC, de Melker HE, Spanjaard L, Schouls LM, van Derende A.

Pediatr Infect Dis J. 2006 Jan;25(1):79-80.

PMID:
16395110

Supplemental Content

Loading ...
Support Center